LİNKLER & KAYNAKLAR

1: Yüksel MK, İlhan O. JACIE: A 20 year-old voluntary body functioning worldwide. Transfus Apher Sci. 2018 Apr;57(2):153-158. doi: 10.1016/j.transci.2018.04.012. Epub 2018 Apr 18. Review. PubMed PMID: 29801765.

2: Yıldız S, Demirkan F. What is the evidence for the role of therapeutic apheresis in the management of complement-associated thrombotic microangiopathies? Transfus Apher Sci. 2018 Feb;57(1):31-34. doi: 10.1016/j.transci.2018.02.013. Epub 2018 Feb 21. Review. PubMed PMID: 29506907.

3: Tekgündüz E, Yılmaz M, Erkurt MA, Kiki I, Kaya AH, Kaynar L, Alacacioglu I, Cetin G, Ozarslan I, Kuku I, Sincan G, Salim O, Namdaroglu S, Karakus A, Karakus V, Altuntas F, Sari I, Ozet G, Aydogdu I, Okan V, Kaya E, Yildirim R, Yildizhan E, Ozgur G, Ozcebe OI, Payzin B, Akpinar S, Demirkan F. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study. Transfus Apher Sci. 2018 Feb;57(1):27-30. doi: 10.1016/j.transci.2018.02.012. Epub 2018 Feb 20. PubMed PMID: 29503132.

4: Apaydin S. The treatment of ANCA-associated rapidly-progressive glomerulonephritis and Goodpasture syndrome with therapeutic apheresis. Transfus Apher Sci. 2018 Feb;57(1):8-12. doi: 10.1016/j.transci.2018.02.007. Epub 2018 Feb 20. Review. PubMed PMID: 29503131.

5: Tekgunduz SA, Kara A, Bozkaya IO, Cagli A, Ozbek NY. Therapeutic plasma exchange in non-hematooncological disorders in pediatrics: A single center experience. Transfus Apher Sci. 2018 Feb;57(1):20-22. doi: 10.1016/j.transci.2018.02.010. Epub 2018 Feb 21. PubMed PMID: 29501259.

6: Demirkan F, Tekgündüz E. Application of apheresis science in Emergency Medicine. Transfus Apher Sci. 2018 Feb;57(1):1. doi: 10.1016/j.transci.2018.02.015. Epub 2018 Feb 21. PubMed PMID: 29486924.

7: Gurlek Gokcebay D, Akpinar Tekgunduz S. Granulocyte transfusions in the management of neutropenic fever: A pediatric perspective. Transfus Apher Sci. 2018 Feb;57(1):16-19. doi: 10.1016/j.transci.2018.02.009. Epub 2018 Feb 20. Review. PubMed PMID: 29478800.

8: Özgür G, Beyan C. Therapeutic apheresis in the treatment of catastrophic antiphospholipid syndrome. Transfus Apher Sci. 2018 Feb;57(1):13-15. doi: 10.1016/j.transci.2018.02.008. Epub 2018 Feb 20. Review. PubMed PMID: 29478799.

9: Kalayoglu-Besisik S. The use of emergency apheresis in the management of plasma cell disorders. Transfus Apher Sci. 2018 Feb;57(1):35-39. doi: 10.1016/j.transci.2018.02.014. Epub 2018 Feb 20. Review. PubMed PMID: 29477943.

10: Korkmaz S. The management of hyperleukocytosis in 2017: Do we still need leukapheresis? Transfus Apher Sci. 2018 Feb;57(1):4-7. doi: 10.1016/j.transci.2018.02.006. Epub 2018 Feb 20. Review. PubMed PMID: 29477941.

11: Demirsoy ET, Mehtap O, Atesoglu EB, Tarkun P, Eren N, Gedük A, Hacihanefioglu A. Dasatinib-induced immune mediated-thrombotic thrombocytopenic purpura. Transfus Apher Sci. 2018 Apr;57(2):222-224. doi: 10.1016/j.transci.2018.02.003. Epub 2018 Feb 9. PubMed PMID: 29475747.

12: Sevindik OG, Korkmaz S, Altuntas F. Current status of art mobilization in Myeloma. Transfus Apher Sci. 2017 Dec;56(6):850-853. doi: 10.1016/j.transci.2017.11.028. Epub 2017 Nov 21. PubMed PMID: 29174798.

13: Yilmaz F, Soyer N, Uslu R, Tobu M, Karaca B, Saydam G, Sahin F, Vural F. Risk factors for poor mobilization in solid tumors: How effectively can we mobilize patients with solid tumors? Transfus Apher Sci. 2017 Dec;56(6):809-813. doi: 10.1016/j.transci.2017.11.011. Epub 2017 Nov 8. PubMed PMID: 29162401.

14: Goren Sahin D, Arat M. Peripheral blood stem cell collection for allogeneic hematopoietic stem cell transplantation: Practical implications after 200 consequent transplants. Transfus Apher Sci. 2017 Dec;56(6):800-803. doi: 10.1016/j.transci.2017.11.009. Epub 2017 Nov 8. PubMed PMID: 29162402.

15: Altuntaş F, Korkmaz S. Hematopoietic progenitor cell mobilization. Transfus Apher Sci. 2017 Dec;56(6):787. doi: 10.1016/j.transci.2017.11.024. Epub 2017 Nov 11. PubMed PMID: 29162398.

16: Kayıkçı Ö, Tekgündüz E, Kaya AH, Göker H, Aslan A, İskender D, Namdaroglu S, Tetik A, Koçubaba Ş, Altuntaş F. Biosimilar filgrastim (leucostim®) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen®) and lenograstim (granocyte®): A retrospective multicenter study. Transfus Apher Sci. 2017 Dec;56(6):832-835. doi: 10.1016/j.transci.2017.11.016. Epub 2017 Nov 10. PubMed PMID: 29162397.

17: Karasu G, Uygun V, Yesilipek A. Factors associated with peripheral blood stem cell yield in healthy pediatric donors. Transfus Apher Sci. 2017 Dec;56(6):819-824. doi: 10.1016/j.transci.2017.11.013. Epub 2017 Nov 8. PubMed PMID: 29162396.

18: Kiki I. What is the role of apheresis technology in stem cell transplantation? Transfus Apher Sci. 2017 Dec;56(6):788-794. doi: 10.1016/j.transci.2017.11.007. Epub 2017 Nov 8. PubMed PMID: 29162394. 19: Namdaroglu S, Korkmaz S, Altuntas F. Management of mobilization failure in 2017. Transfus Apher Sci. 2017 Dec;56(6):836-844. doi: 10.1016/j.transci.2017.11.017. Epub 2017 Nov 8. PubMed PMID: 29153350.

20: Dogu MH, Çagirgan S, Ocakci S, Kaya AH, Ilkkilic K, Sanli NM, Kahraman S, Eren R, Tekgunduz E, Hacioglu S, Kaynar L, Erkurt MA, Altuntas F. Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma. Transfus Apher Sci. 2017 Dec;56(6):814-818. doi: 10.1016/j.transci.2017.11.012. Epub 2017 Nov 8. PubMed PMID: 29153347.

21: Korkmaz S, Altuntas F. What is the role of biosimilar G-CSF agents in hematopoietic stem cell mobilization at present? Transfus Apher Sci. 2017 Dec;56(6):795-799. doi: 10.1016/j.transci.2017.11.008. Epub 2017 Nov 8. PubMed PMID: 29153313.

22: Aksu T, Ok Bozkaya İ, Akpınar Tekgündüz S, Olcar Kanbur M, Köksal Y, Özgüner M, Özbek NY. Two versus three day upfront use of granulocyte-colony stimulating factor in healthy bone marrow donors for pediatric bone marrow transplantation. Transfus Apher Sci. 2017 Dec;56(6):829-831. doi: 10.1016/j.transci.2017.11.015. Epub 2017 Nov 8. PubMed PMID: 29153311.

23: Ocakci S, Kahraman S, Cagirgan S. Age does not matter: Mobilization and harvesting are safe and effective for elderly allogeneic peripheral hematopoietic stem cell donors. Transfus Apher Sci. 2017 Dec;56(6):825-828. doi: 10.1016/j.transci.2017.11.014. Epub 2017 Nov 8. PubMed PMID: 29153310.

24: Malkan UY, Ozcebe OI. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis. Transfus Apher Sci. 2017 Dec;56(6):880-882. doi: 10.1016/j.transci.2017.11.002. Epub 2017 Nov 8. PubMed PMID: 29153308.

25: Tekgündüz E, Arat M, Göker H, Özdoğu H, Kaynar L, Çağırgan S, Erkurt MA, Vural F, Kiki İ, Altuntaş F, Demirkan F; Turkish Society of Apheresis (TSA). Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA). Transfus Apher Sci. 2017 Dec;56(6):845-849. doi: 10.1016/j.transci.2017.11.025. Epub 2017 Nov 10. PubMed PMID: 29153306.

26: Tekgündüz E, Demirkan F, Vural F, Göker H, Özdoğu H, Kiki İ, Aydoğdu İ, Kaynar L, Erkurt MA, Çağırgan S, Beşışık S, Dağdaş S, Koca E, Kadıköylü G, Gündüz E, Yılmaz M, Beköz H, Ural AU, Baştürk A, Arat M, Albayrak M, Öztürk E, Akyol A, Bolaman AZ, Nevruz O, Özkan HA, Özgür G, Altuntaş F. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG). Transfus Apher Sci. 2017 Dec;56(6):804-808. doi: 10.1016/j.transci.2017.11.010. Epub 2017 Nov 9. PubMed PMID: 29153305.

27: Özkurt ZN, Batmaz L, Yeğin ZA, İlhan Ç. Factors affecting hematopoietic stem cell mobilization and apheresis in allogeneic donors: The role of iron status. Transfus Apher Sci. 2017 Jun;56(3):470-473. doi: 10.1016/j.transci.2017.05.021. Epub 2017 Jun 3. PubMed PMID: 28647301.

28: Gerçeker E, Yüceyar H, Kasap E, Demirci U, Ekti BC, Aydoğdu İ, Miskioğlu M. Treatment of inflammatory bowel disease by leukocytapheresis. Transfus Apher Sci. 2017 Jun;56(3):421-426. doi: 10.1016/j.transci.2017.03.016. Epub 2017 Apr 12. PubMed PMID: 28454883.

29: Ataca Atilla P, Bakanay Ozturk SM, Demirer T. How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation? Transfus Apher Sci. 2017 Apr;56(2):190-198. doi: 10.1016/j.transci.2016.11.005. Epub 2016 Dec 26. Review. PubMed PMID: 28034547.